Microbiotica: Microbiotica's first in-human trial commences
Initial ulcerative colitis patients dosed for live biotherapeutic product, MB310.
Read full article »
Microbiotica is an England-based biotechnology company that researches and develops bacterial therapeutics and biomarkers for the treatment of cancer.
Read more